These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39015682)

  • 41. Prediction of survival of patients in cardiogenic shock treated by surgically implanted Impella 5+ short-term left ventricular assist device.
    Nersesian G; Tschöpe C; Spillmann F; Gromann T; Roehrich L; Mueller M; Mulzer J; Starck C; Falk V; Schoenrath F; Potapov E
    Interact Cardiovasc Thorac Surg; 2020 Oct; 31(4):475-482. PubMed ID: 32879947
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of Hemodynamic Support With Impella for Acute Myocardial Infarction Complicated by Cardiogenic Shock at a Rural Community Hospital Without On-Site Surgical Back-up.
    Wilkins CE; Herrera TL; Nagahiro MK; Weathers LB; Girotra SV; Sandhu F
    J Invasive Cardiol; 2019 Feb; 31(2):E23-E29. PubMed ID: 30700627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impella CP use in patients with non-ischaemic cardiogenic shock.
    Maniuc O; Salinger T; Anders F; Müntze J; Liu D; Hu K; Ertl G; Frantz S; Nordbeck P
    ESC Heart Fail; 2019 Aug; 6(4):863-866. PubMed ID: 31095902
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of Impella 5.0 and extracorporeal left ventricular assist device in patients with cardiogenic shock.
    Kondo T; Morimoto R; Mutsuga M; Fujimoto K; Okumura T; Shibata N; Kazama S; Kimira Y; Oishi H; Kuwayama T; Hiraiwa H; Usui A; Murohara T
    Int J Artif Organs; 2021 Nov; 44(11):846-853. PubMed ID: 34488481
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Impella Microaxial Flow Catheter Is Safe and Effective for Treatment of Myocarditis Complicated by Cardiogenic Shock: An Analysis From the Global cVAD Registry.
    Annamalai SK; Esposito ML; Jorde L; Schreiber T; A Hall S; O'Neill WW; Kapur NK
    J Card Fail; 2018 Oct; 24(10):706-710. PubMed ID: 30244180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Temporary circulatory support with surgically implanted microaxial pumps in postcardiotomy cardiogenic shock following coronary artery bypass surgery.
    Sommer W; Arif R; Kremer J; Al Maisary S; Verch M; Tochtermann U; Karck M; Meyer AL; Warnecke G
    JTCVS Open; 2023 Sep; 15():252-260. PubMed ID: 37808068
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Impella device for acute mechanical circulatory support in patients in cardiogenic shock.
    Lemaire A; Anderson MB; Lee LY; Scholz P; Prendergast T; Goodman A; Lozano AM; Spotnitz A; Batsides G
    Ann Thorac Surg; 2014 Jan; 97(1):133-8. PubMed ID: 24090575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival.
    Esposito ML; Jablonski J; Kras A; Krasney S; Kapur NK
    Int J Artif Organs; 2018 Apr; 41(4):236-239. PubMed ID: 29637832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts.
    Tschöpe C; Van Linthout S; Klein O; Mairinger T; Krackhardt F; Potapov EV; Schmidt G; Burkhoff D; Pieske B; Spillmann F
    J Cardiovasc Transl Res; 2019 Apr; 12(2):116-123. PubMed ID: 30084076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long term survival after early unloading with Impella CP
    Loehn T; O'Neill WW; Lange B; Pfluecke C; Schweigler T; Mierke J; Waessnig N; Mahlmann A; Youssef A; Speiser U; Strasser RH; Ibrahim K
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):149-157. PubMed ID: 30456984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impella 5.0 therapy as a bridge-to-decision option for patients on extracorporeal life support with unclear neurological outcomes.
    Bernhardt AM; Zipfel S; Reiter B; Hakmi S; Castro L; Söffker G; Kluge S; Lubos E; Rybczinski M; Grahn H; Schrage B; Becher PM; Barten MJ; Westermann D; Blankenberg S; Reichenspurner H
    Eur J Cardiothorac Surg; 2019 Dec; 56(6):1031-1036. PubMed ID: 31038672
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes of Renal Function in Cardiogenic Shock Patients With or Without Mechanical Circulatory Support.
    Upadhyaya VD; Alshami A; Patel I; Douedi S; Quinlan A; Thomas T; Prentice J; Calderon D; Asif A; Sen S; Mehra A; Hossain MA
    J Clin Med Res; 2021 May; 13(5):283-292. PubMed ID: 34104280
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Secular Trend in the Use and Implementation of Impella in High-Risk Percutaneous Coronary Intervention and Cardiogenic Shock: A Real-World Experience.
    Hritani AW; Wani AS; Olet S; Lauterbach CJ; Allaqaband SQ; Bajwa T; Jan MF
    J Invasive Cardiol; 2019 Sep; 31(9):E265-E270. PubMed ID: 31478893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of the Impella Device for Acute Coronary Syndrome Complicated by Cardiogenic Shock - Experience From a Single Heart Center With Analysis of Long-term Mortality.
    Schroeter MR; Köhler H; Wachter A; Bleckmann A; Hasenfuß G; Schillinger W
    J Invasive Cardiol; 2016 Dec; 28(12):467-472. PubMed ID: 27529657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock.
    Schrage B; Ibrahim K; Loehn T; Werner N; Sinning JM; Pappalardo F; Pieri M; Skurk C; Lauten A; Landmesser U; Westenfeld R; Horn P; Pauschinger M; Eckner D; Twerenbold R; Nordbeck P; Salinger T; Abel P; Empen K; Busch MC; Felix SB; Sieweke JT; Møller JE; Pareek N; Hill J; MacCarthy P; Bergmann MW; Henriques JPS; Möbius-Winkler S; Schulze PC; Ouarrak T; Zeymer U; Schneider S; Blankenberg S; Thiele H; Schäfer A; Westermann D
    Circulation; 2019 Mar; 139(10):1249-1258. PubMed ID: 30586755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock.
    Buda KG; Hryniewicz K; Eckman PM; Basir MB; Cowger JA; Alaswad K; Mukundan S; Sandoval Y; Elliott A; Brilakis ES; Megaly MS
    Eur Heart J Acute Cardiovasc Care; 2024 May; 13(5):390-397. PubMed ID: 38502888
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of Hemodynamic Support by Impella vs. Peripheral Extra-Corporeal Membrane Oxygenation: A Porcine Model of Acute Myocardial Infarction.
    Nix C; Ishikawa K; Meyns B; Yasuda S; Adriaenssens T; Barth S; Zayat R; Leprince P; Lebreton G
    Front Cardiovasc Med; 2020; 7():99. PubMed ID: 32587862
    [No Abstract]   [Full Text] [Related]  

  • 58. Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy.
    Sieweke JT; Pfeffer TJ; Berliner D; König T; Hallbaum M; Napp LC; Tongers J; Kühn C; Schmitto JD; Hilfiker-Kleiner D; Schäfer A; Bauersachs J
    Eur Heart J Acute Cardiovasc Care; 2020 Mar; 9(2):173-182. PubMed ID: 29792513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impella support for cardiogenic shock and high-risk percutaneous coronary intervention: A single-center experience.
    Brandão M; Caeiro D; Pires-Morais G; Almeida JG; Teixeira PG; Silva MP; Ponte M; Dias A; Oliveira M; Rodrigues A; Braga P
    Rev Port Cardiol (Engl Ed); 2021 Nov; 40(11):853-861. PubMed ID: 34857158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Improved clinical outcomes associated with the Impella 5.5 compared to the Impella 5.0 in contemporary cardiogenic shock and heart failure patients.
    Ramzy D; Soltesz EG; Silvestry S; Daneshmand M; Kanwar M; D'Alessandro DA
    J Heart Lung Transplant; 2023 May; 42(5):553-557. PubMed ID: 36841643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.